Case File
efta-efta00977627DOJ Data Set 9OtherFrom: Alan Rogers
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00977627
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Alan Rogers
To: Jeffrey Epstein <[email protected]>
Subject: Re:
Date: Mon, 25 Nov 2013 22:48:34 +0000
My paper was about the evolution of menopause. George Williams had argued years before that as women age,
the risk of childbirth mortality increases. Eventually, that risk outweighs the potential fitness gain from another
child. My paper showed that this doesn't work--the risk of childbirth mortality is too low. I saw more promise in
a hypothesis having to do with opportunity cost. To do these calculations, I needed an age-structured theory of
kin selection with a time delay between the investment (forgone pregnancy) and the return on that investment
(ability to care for one's previous children). So the model had economic pretensions, and I eventually used it to
study the evolution of time preference. It was the time preference work that brought me into contact with Gordon
G.
Alan
On Mon, Nov 25, 2013 at 2:20 PM, Jeffrey Epstein <[email protected]> wrote:
risk of death in childbirth?
On Mon, Nov 25, 2013 at 5:05 PM, Alan Rogers <
> wrote:
Charlesworth and Charnov published an age-structured theory of kin selection in 1981 (JTB 88:103) and
Taylor and Frank did it a different way in 1996 (JTB 180:27). I added time delays to the Charlesworth-
Charnov model in 1993 (Evollutionary Ecology 7:406). These models all grow out of the ideas that
Hamilton introduced in his "Moulding of senescence" paper in 1966. But Hamilton 1966 didn't do kin
selection. He did however argue that reproductive value is not the right way to formulate the problem. His
model (and also those mentioned above) use the numerator of reproductive value, but the normalization is
different. To put this differently, the reproductive value at age x needs to be weighted by l_x, the probability
of surviving to that age. This weighting is missing from the formulation directly in terms of reproductive
value.
Alan
2013/11/25 Gordon Getty
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
EFTA00977627
return e-mail or by e-mail to [email protected] and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00977628
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.